000650.SZ
仁和药业
SZSE · Healthcare · C 制造业 · CN
CNY 5.34
−0.56%Margins
Gross margin
36.9%
EBITDA margin
21.3%
EBIT margin
17.9%
Net margin
10.0%
FCF margin
21.6%
5.7%
Return on equity
4.7%
Return on assets
10.2%
Return on invested capital
0.47x
Asset turnover
CNY 857.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026